Trial Profile
Phase I trial of motexafin gadolinium and docetaxel chemotherapy in the treatment of advanced solid tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jan 2019
Price :
$35
*
At a glance
- Drugs Motexafin gadolinium (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Pharmacyclics
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2005 New trial record.